UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dysfunctional HDL and atherosclerotic cardiovascular disease

Nature reviews cardiology, 2016-01, Vol.13 (1), p.48-60

2016

Volltextzugriff (PDF)

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport

Circulation (New York, N.Y.), 2012-04, Vol.125 (15), p.1905-1919

2012

Volltextzugriff (PDF)

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition

Circulation (New York, N.Y.), 2004-01, Vol.109 (3), p.433-438

2004

Volltextzugriff (PDF)

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

Clinical chemistry (Baltimore, Md.), 2011-03, Vol.57 (3), p.392-410

2011

Volltextzugriff (PDF)

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

European heart journal, 2016-02, Vol.37 (6), p.536-545

2016

Volltextzugriff (PDF)

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Circulation (New York, N.Y.), 2004-07, Vol.110 (2), p.227-239

2004

Volltextzugriff (PDF)

HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology

Nature reviews cardiology, 2018-01, Vol.15 (1), p.9-19

2018

Volltextzugriff (PDF)

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

The New England journal of medicine, 2017-05, Vol.376 (20), p.1933-1942

2017

Volltextzugriff (PDF)

The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease

The journal of clinical endocrinology and metabolism, 2011-05, Vol.96 (5), p.1246-1257

Brewer, H. Bryan

2011

Volltextzugriff (PDF)

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2003-02, Vol.23 (2), p.160-167

2003

Volltextzugriff (PDF)

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

The Lancet (British edition), 2015-08, Vol.386 (9992), p.452-460

2015

Volltextzugriff (PDF)

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Journal of the American College of Cardiology, 2004-08, Vol.44 (3), p.720-732

2004

Volltextzugriff (PDF)

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Arteriosclerosis, thrombosis, and vascular biology, 2004-02, Vol.24 (2), p.e13

2004

Volltextzugriff (PDF)

Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges

Circulation (New York, N.Y.), 2013-09, Vol.128 (11), p.1256-1267

2013

Volltextzugriff (PDF)

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

Arteriosclerosis, thrombosis, and vascular biology, 2004-03, Vol.24 (3), p.387-391

Brewer, Jr, H Bryan

2004

Volltextzugriff (PDF)

Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study

The Lancet (British edition), 2019-11, Vol.394 (10209), p.1629-1637

2019

Volltextzugriff (PDF)

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

The Journal of biological chemistry, 2003-01, Vol.278 (4), p.2563-2570

2003

Volltextzugriff (PDF)

benefit-risk assessment of Rosuvastatin 10 to 40 milligrams

The American journal of cardiology, 2003-08, Vol.92 (4), p.23-29

Brewer, H.Bryan

2003

Volltextzugriff (PDF)

High-density lipoprotein infusion therapy: A review

Journal of clinical lipidology, 2024-05, Vol.18 (3), p.e374-e383

2024

Volltextzugriff (PDF)

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Journal of the American College of Cardiology, 2015-11, Vol.66 (20), p.2201-2210

2015

Volltextzugriff (PDF)

Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity

The Journal of biological chemistry, 2003-11, Vol.278 (46), p.45062-45071

2003

Volltextzugriff (PDF)

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

Journal of the American College of Cardiology, 2010-06, Vol.55 (24), p.2727-2735

2010

Volltextzugriff (PDF)

Two Genes That Map to the STSL Locus Cause Sitosterolemia: Genomic Structure and Spectrum of Mutations Involving Sterolin-1 and Sterolin-2, Encoded by ABCG5 and ABCG8, Respectively

American journal of human genetics, 2001-08, Vol.69 (2), p.278-290

2001

Volltextzugriff (PDF)

Increasing HDL Cholesterol Levels

The New England journal of medicine, 2004-04, Vol.350 (15), p.1491-1494

Brewer, H. Bryan

2004

Volltextzugriff (PDF)

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2011-11, Vol.306 (19), p.2099

2011

Volltextzugriff (PDF)

1 – 25 von 4.654

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.727)
Mit Volltextzugriff
(3.746)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.430)
Life Sciences & Biomedicine
(1.604)
Humans
(1.287)
Female
(702)
Physical Sciences
(668)
Male
(632)
Biological And Medical Sciences
(558)
Physics
(483)
Adult
(443)
Medical Sciences
(392)
Animals
(389)
Middle Aged
(329)
Biochemistry & Molecular Biology
(264)
Technology
(260)
Exact Sciences And Technology
(226)
Aged
(218)
Adolescent
(200)
Physics, Condensed Matter
(197)
Fundamental And Applied Biological Sciences. Psychology
(184)
Chemistry
(175)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(10)
... seit 90 Tagen
(28)

Menü

Weitere Dienste

Einstellungen

Dysfunctional HDL and atherosclerotic cardiovascular disease

Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease

Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

benefit-risk assessment of Rosuvastatin 10 to 40 milligrams

High-density lipoprotein infusion therapy: A review

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity

A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome

Two Genes That Map to the STSL Locus Cause Sitosterolemia: Genomic Structure and Spectrum of Mutations Involving Sterolin-1 and Sterolin-2, Encoded by ABCG5 and ABCG8, Respectively

Increasing HDL Cholesterol Levels

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial

Suchergebnisse filtern